Regulation and roles of bicarbonate transporters in cancer

Frontiers in Physiology

Volumn 5 APR, Issue , 2014, Pages

  Gorbatenko, Andrej ^a   Olesen, Christina W ^a   Boedtkjer, Ebbe ^b   Pedersen, Stine F ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

Acid base regulation; DRA; Intracellular pH; Ion transport; NBCn1

Indexed keywords

BICARBONATE; BICARBONATE SODIUM COTRANSPORTER; BICARBONATE TRANSPORTER; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE IX; CARBONATE DEHYDRATASE XII; CARRIER PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; SLC4A1 PROTEIN; SLC4A10 PROTEIN; SLC4A11 PROTEIN; SLC4A2 PROTEIN; SLC4A3 PROTEIN; SLC4A4 PROTEIN; SLC4A5 PROTEIN; SLC4A6 PROTEIN; SLC4A7 PROTEIN; SLC4A8 PROTEIN; SLC4A9 PROTEIN; SODIUM PROTON EXCHANGE PROTEIN 1; SOLUTE CARRIER FAMILY 4; UNCLASSIFIED DRUG;

ARTICLE; BREAST CARCINOMA; CA12 GENE; CA2 GENE; CA9 GENE; CANCER CELL; CANCER GROWTH; CANCER RESISTANCE; CANCER RISK; CANCER SUSCEPTIBILITY; COLORECTAL ADENOMA; COLORECTAL CANCER; GENE EXPRESSION REGULATION; HUMAN; IN VITRO STUDY; LUNG CANCER; NEOPLASM; NONHUMAN; PH MEASUREMENT; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTON TRANSPORT; REGULATORY MECHANISM; SLC4A1 GENE; SLC4A10 GENE; SLC4A11 GENE; SLC4A2 GENE; SLC4A3 GENE; SLC4A4 GENE; SLC4A5 GENE; SLC4A6 GENE; SLC4A7 GENE; SLC4A8 GENE; SLC4A9 GENE; SOMATIC MUTATION; TUMOR MICROENVIRONMENT;

EID: 84901021936     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00130     Document Type: Article

References (104)

1. Ahmed, S., Thomas, G., Ghoussaini, M., Healey, C. S., Humphreys, M. K., Platte, R., et al. (2009). Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat. Genet. 41, 585-590. doi: 10.1038/ng.354
2. Alper, S. L., and Sharma, A. K. (2013). The SLC26 gene family of anion transporters and channels. Mol. Aspects Med. 34, 494-515. doi: 10.1016/j.mam.2012.07.009
3. Andersen, A. P., Moreira, J., and Pedersen, S. F. (2014). Interactions of ion transporters and channels with cancer cell metabolism and the tumor microenvironment. Philos. Trans. R. Soc. Lond. B Biol. Sci. 369:20130098. doi: 10.1098/rstb.2013.0098
4. Andrew, A. S., Gui, J., Sanderson, A. C., Mason, R. A., Morlock, E. V., Schned, A. R., et al. (2009). Bladder cancer SNP panel predicts susceptibility and survival. Hum. Genet. 125, 527-539. doi: 10.1007/s00439-009-0645-6
5. Antalis, T. M., Reeder, J. A., Gotley, D. C., Byeon, M. K., Walsh, M. D., Henderson, K. W., et al. (1998). Down-regulation of the down-regulated in adenoma (DRA) gene correlates with colon tumor progression. Clin. Cancer Res. 4, 1857-1863.
6. Arturi, F., Russo, D., Bidart, J. M., Scarpelli, D., Schlumberger, M., and Filetti, S. (2001). Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors. Eur. J. Endocrinol. 145, 129-135. doi: 10.1530/eje.0.1450129
7. Baker, J. B., Dutta, D., Watson, D., Maddala, T., Munneke, B. M., Shak, S., et al. (2011). Tumour gene expression predicts response to cetuximab in patients with KRAS wild-type metastatic colorectal cancer. Br. J. Cancer 104, 488-495. doi: 10.1038/sj.bjc.6606054
8. Bartosova, M., Parkkila, S., Pohlodek, K., Karttunen, T. J., Galbavy, S., Mucha, V., et al. (2002). Expression of carbonic anhydrase IX in breast is associated with malignant tissues and is related to overexpression of c-erbB2. J. Pathol. 197, 314-321. doi: 10.1002/path.1120
9. Belickova, M., Merkerova, M. D., Stara, E., Vesela, J., Sponerova, D., Mikulenkova, D., et al. (2013). DNA repair gene variants are associated with an increased risk of myelodysplastic syndromes in a Czech population. J. Hematol. Oncol. 6, 9. doi: 10.1186/1756-8722-6-9
10. Boedtkjer, E., and Aalkjaer, C. (2013). Acid-base transporters modulate cell migration, growth and proliferation: implications for structure development and remodeling of resistance arteries? Trends Cardiovasc. Med. 23, 59-65. doi: 10.1016/j.tcm.2012.09.001
11. Boedtkjer, E., Bunch, L., and Pedersen, S. F. (2012). Physiology, pharmacology and pathophysiology of the pH regulatory transport proteins NHE1 and NBCn1: similarities, differences, and implications for cancer therapy. Curr. Pharm. Des. 18, 1345-1371. doi: 10.2174/138161212799504830
12. 3(-)-cotransport to cellular pH control in human breast cancer: a role for the breast cancer susceptibility locus NBCn1 (SLC4A7). Int. J. Cancer 132, 1288-1299. doi: 10.1002/ijc.27782
13. 3 cotransporter NBCn1 (slc4a7) in mice. AJP Cell Physiol. 294, C591-C603. doi: 10.1152/ajpcell.00281.2007
14. 2+-sensitivity and hypertension development in mice. Circulation 124, 1819-1824. doi: 10.1161/CIRCULATIONAHA.110.015974
15. 3 cotransporter. Kidney Int. 36, 392-402. doi: 10.1038/ki.1989.208
16. Cairns, R. A., Harris, I. S., and Mak, T. W. (2011). Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85-95. doi: 10.1038/nrc2981
17. Cantor, J. R., and Sabatini, D. M. (2012). Cancer cell metabolism: one hallmark, many faces. Cancer Discov. 2, 881-898. doi: 10.1158/2159-8290.CD-12-0345
18. Chapman, J. M., Knoepp, S. M., Byeon, M. K., Henderson, K. W., and Schweinfest, C. W. (2002). The colon anion transporter, down-regulated in adenoma, induces growth suppression that is abrogated by E1A. Cancer Res. 62, 5083-5088.
19. Chen, J., Rocken, C., Hoffmann, J., Kruger, S., Lendeckel, U., Rocco, A., et al. (2005). Expression of carbonic anhydrase 9 at the invasion front of gastric cancers. Gut 54, 920-927. doi: 10.1136/gut.2004.047340
20. Chen, W., Zhong, R., Ming, J., Zou, L., Zhu, B., Lu, X., et al. (2012). The SLC4A7 variant rs4973768 is associated with breast cancer risk: evidence from a case-control study and a meta-analysis. Breast Cancer Res. Treat. 136, 847-857. doi: 10.1007/s10549-012-2309-9
21. Chen, Y., Choong, L. Y., Lin, Q., Philp, R., Wong, C. H., Ang, B. K., et al. (2007). Differential expression of novel tyrosine kinase substrates during breast cancer development. Mol. Cell Proteomics 6, 2072-2087. doi: 10.1074/mcp.M700395-MCP200
22. Chiche, J., Ilc, K., Laferriere, J., Trottier, E., Dayan, F., Mazure, N. M., et al. (2009). Hypoxia-inducible carbonic anhydrase IX and XII promote tumor cell growth by counteracting acidosis through the regulation of the intracellular pH. Cancer Res. 69, 358-368. doi: 10.1158/0008-5472.CAN-08-2470
23. Christianson, T. A., Doherty, J. K., Lin, Y. J., Ramsey, E. E., Holmes, R., Keenan, E. J., et al. (1998). NH2-terminally truncated HER-2/neu protein: relationship with shedding of the extracellular domain and with prognostic factors in breast cancer. Cancer Res. 58, 5123-5129.
24. Crawford, I., Maloney, P. C., Zeitlin, P. L., Guggino, W. B., Hyde, S. C., Turley, H., et al. (1991). Immunocytochemical localization of the cystic fibrosis gene product CFTR. Proc. Natl. Acad. Sci. U.S.A. 88, 9262-9266. doi: 10.1073/pnas.88.20.9262
25. Dalerba, P., Kalisky, T., Sahoo, D., Rajendran, P. S., Rothenberg, M. E., Leyrat, A. A., et al. (2011). Single-cell dissection of transcriptional heterogeneity in human colon tumors. Nat. Biotechnol. 29, 1120-1127. doi: 10.1038/nbt.2038
26. - export. J. Biol. Chem. 285, 26998-27007. doi: 10.1074/jbc.M110.108712
27. De Milito, A., Canese, R., Marino, M. L., Borghi, M., Iero, M., Villa, A., et al. (2010). pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity. Int. J. Cancer 127, 207-219. doi: 10.1002/ijc.25009
28. de Ronde, J. J., Lips, E. H., Mulder, L., Vincent, A. D., Wesseling, J., Nieuwland, M., et al. (2013). SERPINA6, BEX1, AGTR1, SLC26A3, and LAPTM4B are markers of resistance to neoadjuvant chemotherapy in HER2-negative breast cancer. Breast Cancer Res. Treat. 137, 213-223. doi: 10.1007/s10549-012-2340-x
29. Estrella, V., Chen, T., Lloyd, M., Wojtkowiak, J., Cornnell, H. H., Ibrahim-Hashim, A., et al. (2013). Acidity generated by the tumor microenvironment drives local invasion. Cancer Res. 73, 1524-1535. doi: 10.1158/0008-5472.CAN-12-2796
30. Fasching, P. A., Pharoah, P. D., Cox, A., Nevanlinna, H., Bojesen, S. E., Karn, T., et al. (2012). The role of genetic breast cancer susceptibility variants as prognostic factors. Hum. Mol. Genet. 21, 3926-3939. doi: 10.1093/hmg/dds159
31. Fernandez-Navarro, P., Pita, G., Santamarina, C., Moreno, M. P., Vidal, C., Miranda-Garcia, J., et al. (2013). Association analysis between breast cancer genetic variants and mammographic density in a large population-based study (Determinants of Density in Mammographies in Spain) identifies susceptibility loci in TOX3 gene. Eur. J. Cancer 49, 474-481. doi: 10.1016/j.ejca.2012.08.026
32. Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., et al. (2011). COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 39, D945-D950. doi: 10.1093/nar/gkq929
33. Galeza-Kulik, M., Zebracka, J., Szpak-Ulczok, S., Czarniecka, A. K., Kukulska, A., Gubala, E., et al. (2006). [Expression of selected genes involved in transport of ions in papillary thyroid carcinoma]. Endokrynol. Pol. 57(Suppl. A), 26-31.
34. Gatenby, R. A., and Gillies, R. J. (2008). A microenvironmental model of carcinogenesis. Nat. Rev. Cancer 8, 56-61. doi: 10.1038/nrc2255
35. Gerber, J. M., Gucwa, J. L., Esopi, D., Gurel, M., Haffner, M. C., Vala, M., et al. (2013). Genome-wide comparison of the transcriptomes of highly enriched normal and chronic myeloid leukemia stem and progenitor cell populations. Oncotarget 4, 715-728.
36. Goldman, M., Craft, B., Swatloski, T., Ellrott, K., Cline, M., Diekhans, M., et al. (2013). The UCSC cancer genomics browser: update 2013. Nucleic Acids Res. 41, D949-D954. doi: 10.1093/nar/gks1008
37. 3cotransporter NBCn1 (SLC4A7) by a constitutively active ErbB2 receptor in MCF-7 breast cancer cells. FASEB J. 28, 350-363. doi: 10.1096/fj.13-233288
38. Halestrap, A. P. (2013). The SLC16 gene family - Structure, role and regulation in health and disease. Mol. Aspects Med. 34, 337-349. doi: 10.1016/j.mam.2012.05.003
39. Han, W., Woo, J. H., Yu, J. H., Lee, M. J., Moon, H. G., Kang, D., et al. (2011). Common genetic variants associated with breast cancer in Korean women and differential susceptibility according to intrinsic subtype. Cancer Epidemiol. Biomarkers Prev. 20, 793-798. doi: 10.1158/1055-9965.EPI-10-1282
40. Hemminki, A., Hoglund, P., Pukkala, E., Salovaara, R., Jarvinen, H., Norio, R., et al. (1998). Intestinal cancer in patients with a germline mutation in the down-regulated in adenoma (DRA) gene. Oncogene 16, 681-684. doi: 10.1038/sj.onc.1201538
41. Hoglund, P., Haila, S., Socha, J., Tomaszewski, L., Saarialho-Kere, U., Karjalainen-Lindsberg, M. L., et al. (1996). Mutations of the Down-regulated in adenoma (DRA) gene cause congenital chloride diarrhoea. Nat. Genet. 14, 316-319. doi: 10.1038/ng1196-316
42. Hulikova, A., Harris, A. L., Vaughan-Jones, R. D., and Swietach, P. (2013). Regulation of intracellular pH in cancer cell lines under normoxia and hypoxia. J. Cell Physiol. 228, 743-752. doi: 10.1002/jcp.24221
43. 3 buffer in the regulation of intracellular pH of three-dimensional tumor growths. J. Biol. Chem. 286, 13815-13826. doi: 10.1074/jbc.M111.219899
44. Hwang, J. M., Kao, S. H., Hsieh, Y. H., Li, K. L., Wang, P. H., Hsu, L. S., et al. (2009). Reduction of anion exchanger 2 expression induces apoptosis of human hepatocellular carcinoma cells. Mol. Cell Biochem. 327, 135-144. doi: 10.1007/s11010-009-0051-3
45. Ibrahim-Hashim, A., Cornnell, H. H., Abrahams, D., Lloyd, M., Bui, M., Gillies, R. J., et al. (2012). Systemic buffers inhibit carcinogenesis in TRAMP mice. J. Urol. 188, 624-631. doi: 10.1016/j.juro.2012.03.113
46. Iwata, T., Yoshida, T., Teranishi, M., Murata, Y., Hayashi, Y., Kanou, Y., et al. (2011). Influence of dietary iodine deficiency on the thyroid gland in Slc26a4-null mutant mice. Thyroid Res. 4, 10. doi: 10.1186/1756-6614-4-10
47. 3- exchange in rabbit, rat, and human duodenum. Gastroenterology 122, 709-724. doi: 10.1053/gast.2002.31875
48. Kim, H. S., Kim, d. H., Kim, J. Y., Jeoung, N. H., Lee, I. K., Bong, J. G., et al. (2010). Microarray analysis of papillary thyroid cancers in Korean. Korean J. Intern. Med. 25, 399-407. doi: 10.3904/kjim.2010.25.4.399
49. Kroemer, G., and Pouyssegur, J. (2008). Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 13, 472-482. doi: 10.1016/j.ccr.2008.05.005
50. Lauriola, M., Ugolini, G., Rosati, G., Zanotti, S., Montroni, I., Manaresi, A., et al. (2010). Identification by a Digital Gene Expression Displayer (DGED) and test by RT-PCR analysis of new mRNA candidate markers for colorectal cancer in peripheral blood. Int. J. Oncol. 37, 519-525. doi: 10.3892/ijo_00000701
51. Lauritzen, G., Jensen, M. B., Boedtkjer, E., Dybboe, R., Aalkjaer, C., Nylandsted, J., et al. (2010). NBCn1 and NHE1 expression and activity in ΔNErbB2 receptor-expressing MCF-7 breast cancer cells: contributions to pHi regulation and chemotherapy resistance. Exp. Cell Res. 316, 2538-2553. doi: 10.1016/j.yexcr.2010.06.005
52. 3 cotransporter NBCn1, regulates motility of MCF7 breast cancer cells expressing constitutively active ErbB2. Cancer Lett. 317, 172-183. doi: 10.1016/j.canlet.2011.11.023
53. Long, J., Shu, X. O., Cai, Q., Gao, Y. T., Zheng, Y., Li, G., et al. (2010). Evaluation of breast cancer susceptibility loci in Chinese women. Cancer Epidemiol. Biomarkers Prev. 19, 2357-2365. doi: 10.1158/1055-9965.EPI-10-0054
54. Martin, N. K., Robey, I. F., Gaffney, E. A., Gillies, R. J., Gatenby, R. A., and Maini, P. K. (2012). Predicting the safety and efficacy of buffer therapy to raise tumour pHe: an integrative modelling study. Br. J. Cancer 106, 1280-1287. doi: 10.1038/bjc.2012.58
55. Matias-Guiu, X., and Prat, J. (2013). Molecular pathology of endometrial carcinoma. Histopathology 62, 111-123. doi: 10.1111/his.12053
56. Mencia, N., Selga, E., Noe, V., and Ciudad, C. J. (2011). Underexpression of miR-224 in methotrexate resistant human colon cancer cells. Biochem. Pharmacol. 82, 1572-1582. doi: 10.1016/j.bcp.2011.08.009
57. + stoichiometry in mouse choroid plexus epithelial cells. Biochem. Biophys. Res. Commun. 373, 550-554. doi: 10.1016/j.bbrc.2008.06.053
58. Mosakhani, N., Lahti, L., Borze, I., Karjalainen-Lindsberg, M. L., Sundstrom, J., Ristamaki, R., et al. (2012). MicroRNA profiling predicts survival in anti-EGFR treated chemorefractory metastatic colorectal cancer patients with wild-type KRAS and BRAF. Cancer Genet. 205, 545-551. doi: 10.1016/j.cancergen.2012.08.003
59. Mulligan, A. M., Couch, F. J., Barrowdale, D., Domchek, S. M., Eccles, D., Nevanlinna, H., et al. (2011). Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Breast Cancer Res. 13, R110. doi: 10.1186/bcr3052
60. Padua, R. A., Warren, N., Grimshaw, D., Smith, M., Lewis, C., Whittaker, J., et al. (1997). The cystic fibrosis delta F508 gene mutation and cancer. Hum. Mutat. 10, 45-48. doi: 10.1002/(SICI)1098-1004(1997)10:1<45::AID-HUMU6>3.0.CO;2-L
61. Parker, M. D., and Boron, W. F. (2013). The divergence, actions, roles, and relatives of sodium-coupled bicarbonate transporters. Physiol. Rev. 93, 803-959. doi: 10.1152/physrev.00023.2012
62. - self-exchange activity. J. Biol. Chem. 283, 12777-12788. doi: 10.1074/jbc.M707829200
63. Parks, S. K., Chiche, J., and Pouyssegur, J. (2013). Disrupting proton dynamics and energy metabolism for cancer therapy. Nat. Rev. Cancer 13, 611-623. doi: 10.1038/nrc3579
64. Pedersen, S. F., and Stock, C. (2013). Ion channels and transporters in cancer: pathophysiology, regulation, and clinical potential. Cancer Res. 73, 1658-1661. doi: 10.1158/0008-5472.CAN-12-4188
65. Perez-Sayans, M., Suarez-Penaranda, J. M., Pilar, G. D., Supuran, C. T., Pastorekova, S., Barros-Angueira, F., et al. (2012). Expression of CA-IX is associated with advanced stage tumors and poor survival in oral squamous cell carcinoma patients. J. Oral. Pathol. Med. 41, 667-674. doi: 10.1111/j.1600-0714.2012.01147.x
66. Porra, V., Bernier-Valentin, F., Trouttet-Masson, S., Berger-Dutrieux, N., Peix, J. L., Perrin, A., et al. (2002). Characterization and semiquantitative analyses of pendrin expressed in normal and tumoral human thyroid tissues. J. Clin. Endocrinol. Metab. 87, 1700-1707. doi: 10.1210/jcem.87.4.8372
67. + exchanger-dependent intracellular alkalinization is an early event in malignant transformation and plays an essential role in the development of subsequent transformation-associated phenotypes. FASEB J. 14, 2185-2197. doi: 10.1096/fj.00-0029com
68. + exchanger, pH regulation and cancer. Recent Pat. Anticancer Drug Discov. 8, 85-99. doi: 10.2174/1574892811308010085
69. Ro, H. A., and Carson, J. H. (2004). pH microdomains in oligodendrocytes. J. Biol. Chem. 279, 37115-37123. doi: 10.1074/jbc.M403099200
70. Robey, I. F., Baggett, B. K., Kirkpatrick, N. D., Roe, D. J., Dosescu, J., Sloane, B. F., et al. (2009). Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res. 69, 2260-2268. doi: 10.1158/0008-5472.CAN-07-5575
71. Robey, I. F., and Nesbit, L. A. (2013). Investigating mechanisms of alkalinization for reducing primary breast tumor invasion. Biomed. Res. Int. 2013, 485196. doi: 10.1155/2013/485196
72. 3) transporters. Mol. Aspects Med. 34, 159-182. doi: 10.1016/j.mam.2012.10.008
73. + exchanger for tumor growth. Cancer Res. 49, 205-211.
74. Schwab, A., Fabian, A., Hanley, P. J., and Stock, C. (2012). Role of ion channels and transporters in cell migration. Physiol. Rev. 92, 1865-1913. doi: 10.1152/physrev.00018.2011
75. 3 cotransport in migration of transformed renal epithelial cells. J. Physiol. 568, 445-458. doi: 10.1113/jphysiol.2005.092957
76. Schweinfest, C. W., Henderson, K. W., Suster, S., Kondoh, N., and Papas, T. S. (1993). Identification of a colon mucosa gene that is down-regulated in colon adenomas and adenocarcinomas. Proc. Natl. Acad. Sci. U.S.A. 90, 4166-4170. doi: 10.1073/pnas.90.9.4166
77. Schweinfest, C. W., Spyropoulos, D. D., Henderson, K. W., Kim, J. H., Chapman, J. M., Barone, S., et al. (2006). slc26a3 (dra)-deficient mice display chloride-losing diarrhea, enhanced colonic proliferation, and distinct up-regulation of ion transporters in the colon. J. Biol. Chem. 281, 37962-37971. doi: 10.1074/jbc.M607527200
78. +-ATPase in human breast cancer cells with distinct metastatic potential: distribution and functional activity. Am. J. Physiol. Cell Physiol. 286, C1443-C1452. doi: 10.1152/ajpcell.00407.2003
79. Shen, W. W., Wu, J., Cai, L., Liu, B. Y., Gao, Y., Chen, G. Q., et al. (2007). Expression of anion exchanger 1 sequestrates p16 in the cytoplasm in gastric and colonic adenocarcinoma. Neoplasia 9, 812-819. doi: 10.1593/neo.07403
80. Silva, A. S., Yunes, J. A., Gillies, R. J., and Gatenby, R. A. (2009). The potential role of systemic buffers in reducing intratumoral extracellular pH and acid-mediated invasion. Cancer Res. 69, 2677-2684. doi: 10.1158/0008-5472.CAN-08-2394
81. Song, L. J., Liu, R. J., Zeng, Z., Alper, S. L., Cui, H. J., Lu, Y., et al. (2012). Gastrin inhibits a novel, pathological colon cancer signaling pathway involving EGR1, AE2, and P-ERK. J. Mol. Med. (Berl.) 90, 707-718. doi: 10.1007/s00109-011-0851-2
82. Sonveaux, P., Vegran, F., Schroeder, T., Wergin, M. C., Verrax, J., Rabbani, Z. N., et al. (2008). Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J. Clin. Invest. 118, 3930-3942. doi: 10.1172/JCI36843
83. + exchanger NHE1 in cell migration. Acta Physiol. 187, 149-157. doi: 10.1111/j.1748-1716.2006.01543.x
84. Sueta, A., Ito, H., Kawase, T., Hirose, K., Hosono, S., Yatabe, Y., et al. (2012). A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese population. Breast Cancer Res. Treat. 132, 711-721. doi: 10.1007/s10549-011-1904-5
85. Suo, W. H., Zhang, N., Wu, P. P., Zhao, L., Song, L. J., Shen, W. W., et al. (2012). Anti-tumour effects of small interfering RNA targeting anion exchanger 1 in experimental gastric cancer. Br. J. Pharmacol. 165, 135-147. doi: 10.1111/j.1476-5381.2011.01521.x
86. Supuran, C. T. (2008). Carbonic anhydrases-an overview. Curr. Pharm. Des. 14, 603-614. doi: 10.2174/138161208783877884
87. + exchanger isoform-1. J. Biol. Chem. 274, 20206-20214. doi: 10.1074/jbc.274.29.20206
88. Tian, H., Zhang, N., Suo, W. H., Wang, T., Song, L. J., Wu, J., et al. (2010). Gastrin suppresses the interdependent expression of p16 and anion exchanger 1 favoring growth inhibition of gastric cancer cells. Int. J. Cancer 127, 1462-1474. doi: 10.1002/ijc.25124
89. Tokuhiro, S., Yamada, R., Chang, X., Suzuki, A., Kochi, Y., Sawada, T., et al. (2003). An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis. Nat. Genet. 35, 341-348. doi: 10.1038/ng1267
90. Vaupel, P. (2004). Tumor microenvironmental physiology and its implications for radiation oncology. Semin. Radiat. Oncol. 14, 198-206. doi: 10.1016/j.semradonc.2004.04.008
91. Vaupel, P. W., Frinak, S., and Bicher, H. I. (1981). Heterogeneous oxygen partial pressure and pH distribution in C3H mouse mammary adenocarcinoma. Cancer Res. 41, 2008-2013.
92. 3 cotransporter (NBCe2). Am. J. Physiol. Cell Physiol. 282, C1278-C1289. doi: 10.1152/ajpcell.00589.2001
93. Wang, T., Zhao, L., Yang, Y., Tian, H., Suo, W. H., Yan, M., et al. (2013). EGR1 is critical for gastrin-dependent upregulation of anion exchanger 2 in gastric cancer cells. FEBS J. 280, 174-183. doi: 10.1111/febs.12058
94. Webb, B. A., Chimenti, M., Jacobson, M. P., and Barber, D. L. (2011). Dysregulated pH: a perfect storm for cancer progression. Nat. Rev. Cancer 11, 671-677. doi: 10.1038/nrc3110
95. Wojtkowiak, J. W., Verduzco, D., Schramm, K. J., and Gillies, R. J. (2011). Drug resistance and cellular adaptation to tumor acidic pH microenvironment. Mol. Pharm. 8, 2032-2038. doi: 10.1021/mp200292c
96. Wu, J., Zhang, Y. C., Suo, W. H., Liu, X. B., Shen, W. W., Tian, H., et al. (2010). Induction of anion exchanger-1 translation and its opposite roles in the carcinogenesis of gastric cancer cells and differentiation of K562 cells. Oncogene 29, 1987-1996. doi: 10.1038/onc.2009.481
97. Wu, T. T., Hsieh, Y. H., Wu, C. C., Tsai, J. H., Hsieh, Y. S., Huang, C. Y., et al. (2006). Overexpression of anion exchanger 2 in human hepatocellular carcinoma. Chin. J. Physiol. 49, 192-198.
98. Xing, M., Tokumaru, Y., Wu, G., Westra, W. B., Ladenson, P. W., and Sidransky, D. (2003). Hypermethylation of the Pendred syndrome gene SLC26A4 is an early event in thyroid tumorigenesis. Cancer Res. 63, 2312-2315.
99. Xu, W. Q., Song, L. J., Liu, Q., Zhao, L., Zheng, L., Yan, Z. W., et al. (2009). Expression of anion exchanger 1 is associated with tumor progress in human gastric cancer. J. Cancer Res. Clin. Oncol. 135, 1323-1330. doi: 10.1007/s00432-009-0573-9
100. Yang, Y., Wu, P. P., Wu, J., Shen, W. W., Wu, Y. L., Fu, A. F., et al. (2008). Expression of anion exchanger 2 in human gastric cancer. Exp. Oncol. 30, 81-87.
101. Yoshitomi, K., Burckhardt, B. C., and Fromter, E. (1985). Rheogenic sodium-bicarbonate cotransport in the peritubular cell membrane of rat renal proximal tubule. Pflugers Arch. 405, 360-366. doi: 10.1007/BF00595689
102. You, H., Jin, J., Shu, H., Yu, B., De, M. A., Lozupone, F., et al. (2009). Small interfering RNA targeting the subunit ATP6L of proton pump V-ATPase overcomes chemoresistance of breast cancer cells. Cancer Lett. 280, 110-119. doi: 10.1016/j.canlet.2009.02.023
103. Yusa, A., Miyazaki, K., Kimura, N., Izawa, M., and Kannagi, R. (2010). Epigenetic silencing of the sulfate transporter gene DTDST induces sialyl Lewisx expression and accelerates proliferation of colon cancer cells. Cancer Res. 70, 4064-4073. doi: 10.1158/0008-5472.CAN-09-2383
104. Zhu, J., Sanborn, J. Z., Benz, S., Szeto, C., Hsu, F., Kuhn, R. M., et al. (2009). The UCSC cancer genomics browser. Nat. Methods 6, 239-240. doi: 10.1038/nmeth0409-239